Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

Amy A. Mrazek; Celia Chao

doi:10.1016/j.suc.2014.07.003

Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

Amy A. Mrazek
, Celia Chao

Research output: Contribution to journal › Review article › peer-review

37 Scopus citations

Abstract

The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

Original language	English (US)
Pages (from-to)	989-1002
Number of pages	14
Journal	Surgical Clinics of North America
Volume	94
Issue number	5
DOIs	https://doi.org/10.1016/j.suc.2014.07.003
State	Published - Oct 1 2014
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2014 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Management of recurrence
Melanoma survivorship
Surveillance and follow-up
Survival prognosis

Publisher link

10.1016/j.suc.2014.07.003

Find It

Find It at U of M Libraries

Cite this

@article{8cd6c285a7f9421aad37d38bc5306388,

title = "Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence",

abstract = "The number of melanoma survivors in the United States continues to steadily increase 2.6\% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.",

keywords = "Management of recurrence, Melanoma survivorship, Surveillance and follow-up, Survival prognosis",

author = "Mrazek, \{Amy A.\} and Celia Chao",

note = "Publisher Copyright: {\textcopyright} 2014 Elsevier Inc.",

year = "2014",

month = oct,

day = "1",

doi = "10.1016/j.suc.2014.07.003",

language = "English (US)",

volume = "94",

pages = "989--1002",

journal = "Surgical Clinics of North America",

issn = "0039-6109",

publisher = "W.B. Saunders",

number = "5",

}

TY - JOUR

T1 - Surviving Cutaneous Melanoma

T2 - A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

AU - Mrazek, Amy A.

AU - Chao, Celia

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

AB - The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

KW - Management of recurrence

KW - Melanoma survivorship

KW - Surveillance and follow-up

KW - Survival prognosis

UR - https://www.scopus.com/pages/publications/84907624135

UR - https://www.scopus.com/pages/publications/84907624135#tab=citedBy

U2 - 10.1016/j.suc.2014.07.003

DO - 10.1016/j.suc.2014.07.003

M3 - Review article

C2 - 25245963

AN - SCOPUS:84907624135

SN - 0039-6109

VL - 94

SP - 989

EP - 1002

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

IS - 5

ER -

Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this